A ClinicalTrials.gov listing describes a proposed evaluation of CEA-PRIT 2.0 in people with metastatic microsatellite-stable colorectal cancer whose disease has progressed after, or who cannot tolerate, available standard therapies.
A planned ambulatory-care study will test whether patient prompts and clinician education encourage conversations about sulfonylureas and possible alternatives among older adults with type 2 diabetes.
Read More
ADEPT-2 is listed as a Phase 3 randomized, double-blind, placebo-controlled study assessing KarXT in people with psychosis associated with Alzheimer’s disease.
Read More
A ClinicalTrials.gov record lists MARITIME-1-EXTENSION, a follow-on trial intended to assess the long-term efficacy, safety and tolerability of maridebart cafraglutide in people with obesity or overweight.
Read More
A report said 150 research primates developed diarrhea during a study, but the available information does not identify the facility, species, cause, protocol or resulting findings.
Read More